Abbott Looks to Consumer for Growth - WSJ.com. Related articles Gilead Shares Rise on Hepatitis C Treatment (minyanville.com) Hep C drugs bring high cure rates in trial (todayonline.com) Abbott's three oral hepatitis C drugs produce high cure rates in trial (medcitynews.com) Abbot Holding Steady For Long-Term Investments (seekingalpha.com) Big Corporate Breakups In 2011 (forbes.com) Abbott … Continue reading Abbott Looks to Consumer for Growth
You must be logged in to post a comment.